Karo Pharma AB (Karo Pharma AB) Additional Paid-In Capital : $845.5 Mil(As of Jun. 2022)

View and export this data going back to . Start your Free Trial

What is Karo Pharma AB Additional Paid-In Capital?

Karo Pharma AB's quarterly additional paid-in capital declined from Sep. 2021 ($695.3 Mil) to Dec. 2021 ($661.2 Mil) but then increased from Dec. 2021 ($661.2 Mil) to Jun. 2022 ($845.5 Mil).

Karo Pharma AB's annual additional paid-in capital increased from Dec. 2019 ($637.2 Mil) to Dec. 2020 ($718.7 Mil) but then declined from Dec. 2020 ($718.7 Mil) to Dec. 2021 ($661.2 Mil).

Karo Pharma AB Additional Paid-In Capital Historical Data

The historical data trend for Karo Pharma AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Additional Paid-In Capital Chart

Karo Pharma AB Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Additional Paid-In Capital

Get a 7-Day Free Trial

313.02

449.16

637.19

718.66

661.22

Karo Pharma AB Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22
Additional Paid-In Capital	Get a 7-Day Free Trial															704.58	728.13	695.32	661.22	845.53

Karo Pharma AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Karo Pharma AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Karo Pharma AB (Karo Pharma AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22

Website

https://www.karopharma.com

Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire • 06-25-2019